Blogroll

Pages

mardi 8 mars 2016

weight loss fitnessCardiovascular safety of obesity treatment naltrexone-bupropion uncertain

The cardiovascular safety of the obesity treatment naltrexone-bupropion remains uncertain because of the unanticipated early termination of a trial to determine its safety, according to a study...

from Obesity / Weight Loss / Fitness News From Medical News Today http://ift.tt/1R3RAyJ

0 commentaires:

Enregistrer un commentaire